Notably, simultaneous silencing of β-catenin and IL-17RA more strongly inhibited tumorigenicity and tumor growth compared to single-gene silencing in miR-125a-overexpressing stromal cell xenografts (Figure 3F). The gene discussed is IL17RA; the disease is neoplasm.